Valeant CEO says no need to adjust offer for Allergan

Tue Jun 17, 2014 9:29am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

June 17 (Reuters) - Valeant Pharmaceuticals Inc Chief Executive Officer Mike Pearson said on Tuesday that he sees no need to adjust the company's offer for Allergan Inc .

Valeant's bid includes both stock and cash, but its shares have fallen for 10 straight sessions. (Reporting by Rod Nickel in Winnipeg, Manitoba)